BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26616505)

  • 1. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
    Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
    Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary management of critical lower limb ischemia in TASC D lesions with subintimal angioplasty in femoro-popliteal lesions, tibial angioplasty and sequential compression biomechanical device for infra-inguinal arterial occlusion. Experience and quality of life outcome learned over 25 years.
    Sultan S; Hynes N
    J Cardiovasc Surg (Torino); 2014 Dec; 55(6):813-25. PubMed ID: 25216216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.
    Barshes NR; Kougias P; Ozaki CK; Goodney PP; Belkin M
    J Vasc Surg; 2014 Aug; 60(2):369-374.e1. PubMed ID: 24657067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
    J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices.
    Brizzi V; Caradu C; Berard X; Sassoust G; Midy D; Ducasse E
    J Cardiovasc Surg (Torino); 2018 Oct; 59(5):707-715. PubMed ID: 27879958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Analysis of Initial Treatment With Endovascular Revascularization, Open Surgery, or Primary Major Amputation in Patients With Peripheral Artery Disease.
    Tang L; Paravastu SCV; Thomas SD; Tan E; Farmer E; Varcoe RL
    J Endovasc Ther; 2018 Aug; 25(4):504-511. PubMed ID: 29756521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.
    Hunt BD; Popplewell MA; Davies H; Meecham L; Jarrett H; Bate G; Grant M; Patel S; Hewitt C; Andronis L; Deeks JJ; Bradbury A;
    Trials; 2017 May; 18(1):224. PubMed ID: 28526046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia.
    Thott O; Granath F; Malmstedt J; Wahlgren CM
    Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):403-410. PubMed ID: 28131536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program.
    Ramanan B; Ahmed A; Wu B; Causey MW; Gasper WJ; Vartanian SM; Reyzelman AM; Hiramoto JS; Conte MS
    J Vasc Surg; 2017 Dec; 66(6):1765-1774. PubMed ID: 28823866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia.
    Singh GD; Armstrong EJ; Yeo KK; Singh S; Westin GG; Pevec WC; Dawson DL; Laird JR
    J Vasc Surg; 2014 May; 59(5):1300-7. PubMed ID: 24393279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.
    Lo RC; Bensley RP; Dahlberg SE; Matyal R; Hamdan AD; Wyers M; Chaikof EL; Schermerhorn ML
    J Vasc Surg; 2014 Feb; 59(2):409-418.e3. PubMed ID: 24080134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tibial angioplasty for limb salvage in high-risk patients and cost analysis.
    Werneck CC; Lindsay TF
    Ann Vasc Surg; 2009; 23(5):554-9. PubMed ID: 19632085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular treatment of lesions in the below-knee popliteal artery.
    Siracuse JJ; Gill HL; Cassidy SP; Messina MD; Catz D; Egorova N; Parrack I; McKinsey JF
    J Vasc Surg; 2014 Aug; 60(2):356-61. PubMed ID: 24650745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of femoropopliteal stenting. Results of a prospective study.
    Schönefeld E; Torsello G; Osada N; Herten M; Bisdas T; Donas KP
    J Cardiovasc Surg (Torino); 2013 Oct; 54(5):617-23. PubMed ID: 24002391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.
    Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S;
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
    Bertges DJ; White R; Cheng YC; Sun T; Ramkumar N; Goodney PP; Wilgus RW; Lottes AE; Smale JA; Drozda J; Raska M; Heise T; Jones WS; Tcheng JE; Eldrup-Jorgensen J; Sedrakyan A; Malone ML; Marinac-Dabic D; Thatcher R; Morales P; Krucoff MW; Cronenwett JL;
    J Vasc Surg; 2021 May; 73(5):1702-1714.e11. PubMed ID: 33080324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    J Vasc Surg; 2019 Jun; 69(6S):126S-136S. PubMed ID: 31159976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Revascularization in Poor-Risk Patients With Critical Limb Ischemia: The PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia).
    Iida O; Takahara M; Soga Y; Azuma N; Nanto S; Uematsu M;
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1147-1157. PubMed ID: 28595883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss.
    Huntress LA; Fereydooni A; Dardik A; Nassiri N
    Ann Vasc Surg; 2020 Feb; 63():234-240. PubMed ID: 31563654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.